Vadakke Puthiyottil S, Edayattil A, N K S. Pathologic Response to Neoadjuvant Subcutaneous Fixed-Dose Pertuzumab–Trastuzumab (Phesgo®) and Chemotherapy in HER2-Positive Locally Advanced Breast Cancer: A Case Series and Literature Review. apjcc [Internet]. 2May2026 [cited 2May2026];11(3):481-8. Available from: http://www.waocp.com/journal/index.php/apjcc/article/view/1994